Summary:
Eczema Study for Kids and Adults: The ADORING study is evaluating an investigational non-steroidal topical cream for people aged 2 years and older who suffer from moderate to severe eczema, also known as atopic dermatitis (AD).
ADORING is a phase 3 clinical study evaluating the safety and efficacy of tapinarof cream, 1% for the topical treatment of moderate to severe eczema in adults and children aged 2 years and above.
ADORING at a Glance
- Participants: up to 400 adults and children
- Duration: up to 13 weeks
- Administration: daily self-application of cream
People who may be eligible:*
- Been diagnosed with eczema
- for at least 6 months for those 6 years old and above or
- 3 months for those 2 to 5 years old
- Male or female, 2 years of age or older
- Have eczema that covers between 5% and 35% of their body, not including the scalp. NOTE: Participants with eczema only on their palms and soles are not eligible.
*Other criteria will apply